Senior leaders from the United States Food and Drug Administration (FDA), the European Commission and the European Medicines Agency (EMA) reviewed their ongoing cooperative activities, including veterinary medicines as one of the focus subjects (Link). Specific topics discussed were the one-health concept and novel therapies such as stem cells, oncology products and cytokines.
